Savara Announces Patient Journey Map for People Living with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Accepted for Poster Presentation at the CHEST 2024 Annual Meeting
Savara, Inc. (SVRA)
Last savara, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
savarapharma.com/investors/events-presentations
Company Research
Source: Business Wire
Company-Sponsored Industry Symposium to be Held at the CHEST 2024 Annual Meeting LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the acceptance of an abstract for poster presentation at the CHEST 2024 Annual Meeting, taking place October 6-9 in Boston. The Company is also sponsoring an Industry Symposium at the meeting. Details are as follows:Accepted AbstractTitle: “A Patient Journey Map for People Living with Autoimmune Pulmonary Alveolar Proteinosis (aPAP)”Poster Session: Diffuse Lung Disease Abstracts Posters (D)Date and Time: October 8, 2024, 1:45 - 2:30pm EDTCompany-Sponsored SymposiumTitle: “Pulmonary Alveolar Proteinosis: Pathophysiology, Diagnosis, and Management”Location: CHEST Learning TheaterDate and Time: October 8, 2024, 2:00 - 2:45pm EDTSpeaker: Ali Ataya, M.D., Associate Professor of Medicine, University of Florida, Division of Pulmonary and Critical
Show less
Read more
Impact Snapshot
Event Time:
SVRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SVRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SVRA alerts
High impacting Savara, Inc. news events
Weekly update
A roundup of the hottest topics
SVRA
News
- Savara Announces New Employment Inducement GrantBusiness Wire
- Positive Signs As Multiple Insiders Buy Savara Stock [Yahoo! Finance]Yahoo! Finance
- Savara Announces Manuscript on Long-Term Outcomes With Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Published in ERJ Open ResearchBusiness Wire
- Savara Announces Participation in Upcoming Healthcare Investor ConferencesBusiness Wire
- Savara Announces New Employment Inducement GrantBusiness Wire
SVRA
Earnings
- 11/12/24 - In-Line
SVRA
Sec Filings
- 2/14/25 - Form 4
- 2/14/25 - Form SCHEDULE
- 2/11/25 - Form SCHEDULE
- SVRA's page on the SEC website